Menu
GeneBe

rs72646967

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001379200.1(TBX1):c.1216A>C(p.Asn406His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.218 in 1,441,986 control chromosomes in the GnomAD database, including 37,415 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N406S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.19 ( 3490 hom., cov: 32)
Exomes 𝑓: 0.22 ( 33925 hom. )

Consequence

TBX1
NM_001379200.1 missense

Scores

1
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 2.14
Variant links:
Genes affected
TBX1 (HGNC:11592): (T-box transcription factor 1) This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. This gene product shares 98% amino acid sequence identity with the mouse ortholog. DiGeorge syndrome (DGS)/velocardiofacial syndrome (VCFS), a common congenital disorder characterized by neural-crest-related developmental defects, has been associated with deletions of chromosome 22q11.2, where this gene has been mapped. Studies using mouse models of DiGeorge syndrome suggest a major role for this gene in the molecular etiology of DGS/VCFS. Several alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002857238).
BP6
Variant 22-19766568-A-C is Benign according to our data. Variant chr22-19766568-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 263351.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-19766568-A-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.468 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TBX1NM_001379200.1 linkuse as main transcriptc.1216A>C p.Asn406His missense_variant 7/7 ENST00000649276.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TBX1ENST00000649276.2 linkuse as main transcriptc.1216A>C p.Asn406His missense_variant 7/7 NM_001379200.1 A2
TBX1ENST00000332710.8 linkuse as main transcriptc.1189A>C p.Asn397His missense_variant 9/91 P2O43435-3
TBX1ENST00000329705.11 linkuse as main transcriptc.1009+566A>C intron_variant 1 A2O43435-1
TBX1ENST00000359500.7 linkuse as main transcriptc.1009+566A>C intron_variant 1 A2O43435-2

Frequencies

GnomAD3 genomes
AF:
0.185
AC:
27927
AN:
150614
Hom.:
3492
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0457
Gnomad AMI
AF:
0.221
Gnomad AMR
AF:
0.270
Gnomad ASJ
AF:
0.321
Gnomad EAS
AF:
0.485
Gnomad SAS
AF:
0.238
Gnomad FIN
AF:
0.155
Gnomad MID
AF:
0.196
Gnomad NFE
AF:
0.222
Gnomad OTH
AF:
0.207
GnomAD3 exomes
AF:
0.251
AC:
20007
AN:
79850
Hom.:
2801
AF XY:
0.244
AC XY:
11261
AN XY:
46122
show subpopulations
Gnomad AFR exome
AF:
0.0373
Gnomad AMR exome
AF:
0.326
Gnomad ASJ exome
AF:
0.301
Gnomad EAS exome
AF:
0.483
Gnomad SAS exome
AF:
0.224
Gnomad FIN exome
AF:
0.152
Gnomad NFE exome
AF:
0.220
Gnomad OTH exome
AF:
0.226
GnomAD4 exome
AF:
0.221
AC:
285760
AN:
1291264
Hom.:
33925
Cov.:
33
AF XY:
0.222
AC XY:
141502
AN XY:
636556
show subpopulations
Gnomad4 AFR exome
AF:
0.0354
Gnomad4 AMR exome
AF:
0.311
Gnomad4 ASJ exome
AF:
0.307
Gnomad4 EAS exome
AF:
0.471
Gnomad4 SAS exome
AF:
0.226
Gnomad4 FIN exome
AF:
0.162
Gnomad4 NFE exome
AF:
0.217
Gnomad4 OTH exome
AF:
0.220
GnomAD4 genome
AF:
0.185
AC:
27922
AN:
150722
Hom.:
3490
Cov.:
32
AF XY:
0.188
AC XY:
13808
AN XY:
73626
show subpopulations
Gnomad4 AFR
AF:
0.0456
Gnomad4 AMR
AF:
0.270
Gnomad4 ASJ
AF:
0.321
Gnomad4 EAS
AF:
0.484
Gnomad4 SAS
AF:
0.237
Gnomad4 FIN
AF:
0.155
Gnomad4 NFE
AF:
0.222
Gnomad4 OTH
AF:
0.204
Alfa
AF:
0.211
Hom.:
640
Bravo
AF:
0.186
TwinsUK
AF:
0.217
AC:
806
ALSPAC
AF:
0.210
AC:
810
ESP6500AA
AF:
0.0304
AC:
75
ESP6500EA
AF:
0.150
AC:
825
ExAC
AF:
0.143
AC:
12700
Asia WGS
AF:
0.300
AC:
1006
AN:
3342

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpApr 04, 2023- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Dec 16, 2016- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsMay 07, 2018- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
DiGeorge syndrome Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJun 12, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.49
Cadd
Benign
17
Dann
Benign
0.87
Eigen
Benign
-0.92
Eigen_PC
Benign
-0.70
FATHMM_MKL
Benign
0.036
N
LIST_S2
Benign
0.25
T;T
MetaRNN
Benign
0.0029
T;T
MetaSVM
Benign
-1.0
T
MutationTaster
Benign
1.0
P;P;P
PrimateAI
Pathogenic
0.93
D
PROVEAN
Benign
0.91
N;.
REVEL
Benign
0.22
Sift
Benign
1.0
T;.
Sift4G
Benign
1.0
T;.
Vest4
0.072
MPC
0.55
ClinPred
0.0012
T
GERP RS
2.9
gMVP
0.27

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs72646967; hg19: chr22-19754091; COSMIC: COSV60354232; COSMIC: COSV60354232; API